GWM
DRRX

Geneos Wealth Management’s DURECT Corp DRRX Stock Holding History

Geneos Wealth Management’s Portfolio DRRX Stock Details DRRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$6K – 2792
2021
Q3 		$6K Hold
500
– – ﹤0.01% 2381
2021
Q2 		$8K Hold
500
– – ﹤0.01% 2274
2021
Q1 		$9K Hold
500
– – ﹤0.01% 2413
2020
Q4 		$9K Buy
+500
New +$9.51K ﹤0.01% 2247

Other funds holding DRRX

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geneos Wealth Management's DRRX Position: Q4 2021 in Review

Geneos Wealth Management sold out of DURECT Corp (DRRX) in Q4 2021, closing a stake of 500 shares — an estimated $6K sold.

Geneos Wealth Management first reported a position in DRRX in Q4 2020 and held it in 4 quarters. The position peaked at $9K in Q1 2021. 101 funds tracked by Wall St. Rank hold DRRX as of Q4 2021.

  • Geneos Wealth Management reported no remaining DURECT Corp position as of Q4 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 500 DURECT Corp shares in Q4 2021, an estimated $6K.
  • Geneos Wealth Management first reported a position in DURECT Corp in Q4 2020 and held it in 4 quarters.
  • Geneos Wealth Management's DURECT Corp position peaked at $9K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held DURECT Corp as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.